AB0163 Increased eryptosis levels in erythrocytes treated with antibodies from aps patients: eryptos...
AB0163 Increased eryptosis levels in erythrocytes treated with antibodies from aps patients: eryptosis as new actor in aps pathogenesis
About this item
Full title
Author / Creator
Vomero, M. , Ceccarelli, F. , Finucci, A. , Barbati, C. , Colasanti, T. , Pensa, C. , Spinelli, F. R. , Perricone, C. , Novelli, L. , Massaro, L. , Mauro, F. R. , Foà, R. , Conti, F. , Valesini, G. and Alessandri, C.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundErythrocytes (RBCs) are highly sensitive cells constantly exposed to several stress stimuli including inflammatory mediators. Despite the absence of nuclei and the lack of crucial elements in the machinery of apoptosis, they have developed a rapid self-destruction process called eryptosis. During this process the externalization of phosph...
Alternative Titles
Full title
AB0163 Increased eryptosis levels in erythrocytes treated with antibodies from aps patients: eryptosis as new actor in aps pathogenesis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071192668
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071192668
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.6331
